Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0021051 (
immunodeficiency
)
71,517
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Human T-cell leukemia virus (HTLV) type I-related endogenous sequences (HRES) have been cloned from a human genomic library. HRES-1/1 is present in DNA of all normal donors examined. By nucleotide sequence analysis, HRES-1/1 contains two potential open reading frames capable of encoding a p25 and a p15. A 684 bp flanking region 5' from the first ATG codon of p25 contains a TATA-box, a poly-adenylation signal, a putative tRNA primer binding site, and inverted repeats at locations which are typical of a retroviral long terminal repeat. Phylogenetic analysis suggests that HRES-1/1 entered the genome in primates, presumably as an exogenous retrovirus. From the deduced amino acid sequence of HRES-1/1 p25, residues 6-36 show a sequence homology of 32% and 39% to gag region segments of
HTLV-I
and HTLV-II, while residues 104-139 display a sequence homology of 33% and 28% to the gag regions of human
immunodeficiency
virus type 2 (HIV-2) and feline sarcoma virus (FSV), respectively. This suggests that the original exogenous virus infecting primate may be chimeric in structure. The HRES-1/1 genomic locus is transcriptionally active in lymphoid cells, melanoma cells, and embryonic tissues.
...
PMID:Detection and cloning of new HTLV-related endogenous sequences in man. 278 Mar 12
The high prevalence of human
immunodeficiency
virus (HIV-1) infection in populations at risk in Miami prompted a seroepidemiologic study of both HIV-1 and the human T-cell leukemia virus type I (HTLV-I), a closely related virus, in our patients receiving chronic hemodialysis. One hundred twenty-nine patients undergoing hemodialysis in 1986 and 1987 were tested for antibody against both viral antigens by EIA (Abbott Laboratories, Abbott Park, IL). Seroreactive samples for HIV-1 and/or HTLV-I were confirmed by Western blot and, for HTLV-I, by viral cultures. Thirty patients (23.2%) were positive for retroviral infection (22 for HIV-1 alone, four for HTLV-I alone, and four for both HIV-1 and HTLV-I). The most important risk factor was intravenous drug use, followed by blood transfusion. Patients with HIV-1 had lower T4-T8 ratios and higher mortality than those with
HTLV-I infection
alone. It was concluded that HTLV-I, as well as HIV-1, infection is endemic in chronic dialysis centers in Miami. The clinical consequences of
HTLV-I infection
in relatively immunocompromised patients with chronic uremia who are undergoing chronic hemodialysis remains to be established.
...
PMID:Human immunodeficiency virus and human T-cell leukemia virus type I in patients undergoing maintenance hemodialysis in Miami. 278 17
The extent of human T-cell leukemia/lymphoma virus type II (HTLV-II) infection and its rate of spread have been difficult to determine owing to the serological cross-reactivity between
HTLV-I
and HTLV-II. The present study overcame this problem by directly detecting type-specific proviral sequences by means of the polymerase chain reaction (PCR) and liquid hybridization. Screening was performed on a cohort of primarily white intravenous drug abusers (IVDAs), and individuals of other behaviorally defined risk groups from the New York City area. Eleven percent (19 of 169) of the individuals in these high-risk groups were determined by PCR to have HTLV-II proviral infections. One of these patients displayed an exfoliative erythrodermatitis. Thirteen of the 19 subjects were positive in an HTLV-II enzyme-linked immunosorbent assay (ELISA). The remaining six individuals, although negative in the HTLV-II ELISA, were confirmed as HTLV-II positive by analyzing their DNA with a second HTLV-II-specific primer detector system. Four additional individuals were reactive in the HTLV-II ELISA but were PCR-negative for HTLV-II. PCR analysis for
HTLV-I
revealed that all four were positive for that virus. Thirty-seven percent (seven of 19) of the HTLV-II PCR-positive subjects were also PCR-positive for
HTLV-I
, and 84% (16 of 19) of the HTLV-II positive individuals were infected with human
immunodeficiency
virus (HIV-1). Six individuals were triply infected with
HTLV-I
, HTLV-II, and HIV-1.
...
PMID:Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction. 279 Jan 92
Human
immunodeficiency
virus (HIV) infection of MT-4 cells, an
HTLV-I
-transformed T-cell line, proved to be a rapid and sensitive assay system for the detection of potential antiviral drugs effective against the acquired immune deficiency syndrome (AIDS). Four days after HIV inoculation of the MT-4 cells, viral antigen expression was monitored in parallel with indirect immunofluorescence microscopy and laser flow cytofluorography. When 3'-azido-2',3'-dideoxythymidine (AzddThd, AZT) and 2',3'-dideoxycytidine (ddCyd) were evaluated under these conditions, they inhibited viral antigen expression at a minimum (33% inhibitory) concentration of 0.0004 and 0.02 microM, respectively. Similar minimum effective concentrations were found for AzddThd and ddCyd in assays where inhibition of viral cytopathogenicity was based on cell survival. While laser flow cytofluorography could be best adapted for quantitative measurements, cell survival and reconstitution of disrupted cell aggregates gave an equally rapid and sensitive endpoint; and the latter may be ideally suited for preliminary drug screening.
...
PMID:Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus. 282 Oct 48
We have developed a nucleic acid hybridization assay for detecting human
immunodeficiency
virus (HIV) RNA in peripheral blood mononuclear cells. This assay can detect HIV RNA in 10(2) cultured lymphoblastoid cells infected with HIV; it only weakly crossreacts with the RNA of
HTLV-I
or HTLV-II. For 39 (80%) of 49 seropositive subjects, we detected HIV sequences in the RNA from 10(6) peripheral blood mononuclear cells. In contrast, we could not detect HIV DNA in samples of DNA from the same number of cells from any of 39 seropositive individuals tested. Three of 33 seronegative individuals had false-positive results. Nevertheless, because we found an excellent correlation between results from our assay and culture of HIV from peripheral blood mononuclear cells of seropositive subjects, it is unlikely that positive cultures of HIV from these cells reflect latent infection. Nucleic acid hybridization offers a more rapid, simple, and inexpensive alternative to culture for detecting HIV-infected peripheral blood mononuclear cells.
...
PMID:Detecting human immunodeficiency virus RNA in peripheral blood mononuclear cells by nucleic acid hybridization. 282 Nov 28
A new human retrovirus was isolated from a continuous cell line derived from a patient with CD4+ Tac- cutaneous T cell lymphoma/leukemia. This virus is related to but distinct from human T cell leukemia/lymphoma virus types I and II (
HTLV-I
and HTLV-II) and human
immunodeficiency
virus (HIV-1). With the use of a fragment of provirus cloned from one patient with T cell leukemia, closely related sequences were found in DNA of the cell line and of tumor cells from seven other patients with the same disease; these sequences were only distantly related to
HTLV-I
. The phenotype of the cells and the clinical course of the disease were clearly distinguishable from leukemia associated with
HTLV-I
. All patients and the wife of one patient showed a weak serological cross-reactivity with both
HTLV-I
and HIV-1 antigens. None of the patients proved to be at any apparent risk for HIV-1 infection. The name proposed for this virus is HTLV-V, and the date indicate that it may be a primary etiological factor in the major group of cutaneous T cell lymphomas/leukemias, including the sporadic lymphomas known as mycoses fungoides.
...
PMID:HTLV-V: a new human retrovirus isolated in a Tac-negative T cell lymphoma/leukemia. 282 53
We compared the ultrastructure of the human retroviruses by thin-section electron microscopy of infected lymphocytes. Virus particles form at the plasma membrane without involvement of a cytoplasmic precursor. Budding forms of human T-cell leukemia virus types I and II (
HTLV-I
and -II) consist of a crescent-shaped nucleoid separated from the envelope by an intermediate layer. Mature forms of these viruses are about 100 nm in diameter. The nucleoid is electron lucent and almost completely fills the virion. There is about a 10-nm space between the envelope and nucleoid. The envelope has fuzzy surface projections.
HTLV-I
and -II resemble other type C retroviruses in morphology. Budding forms of human
immunodeficiency
virus (HIV, LAV, HTLV-III) also have a crescent-shaped nucleoid but not an intermediate layer between the core and envelope. The envelope has rod-shaped surface projections. Mature forms of HIV have an electron-dense nucleoid that is eccentric and bar- or cone-shaped. Particles have the same ultrastructure as retroviruses of the Lentivirus genus. HIV is readily distinguishable from
HTLV-I
and -II by thin-section electron microscopy. HIV is usually found in extracellular spaces by transmission electron microscopy of thin sections, and scanning electron microscopy of HIV-infected T4 lymphocytes also shows many particles on the surface of these cells. Lymphadenopathy-associated virus type II (LAV-II) has the same internal ultrastructure as HIV, but its surface projections are more prominent, being about three times the length of those of HIV. Human T lymphotropic virus type IV (HTLV-IV) has the same morphology as LAV-II.
...
PMID:Ultrastructure of human retroviruses. 285 53
The relationship between strongyloidiasis and
HTLV-I
was investigated in Okinawa, an area where both conditions are endemic. Thirty-six patients with strongyloidiasis were seropositive for
HTLV-I
and suffered from several related clinical complications. Fourteen of these patients (39%) were shown to have monoclonal integration of
HTLV-I
proviral DNA in their blood lymphocytes, a condition designated as "smouldering" adult T-cell leukaemia (ATL). Monoclonal integration of proviral DNA correlated with an increased CD4/CD8 ratio and the presence of abnormal lymphocytes in the peripheral blood, and with a trend for greater severity of the parasitic infection. Although the
immunodeficiency
caused by
HTLV-I
could predispose to hyperinfestation by Strongyloides, it is also possible that both the parasitic and the retroviral infestations are important co-factors leading to the development of ATL.
...
PMID:Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis. 288 41
Soluble interleukin 2 receptors (IL 2R) from human retrovirus-infected cells were analyzed. All the T cell lines integrated with human T cell lymphotropic virus (HTLV)-I and -II, or transfected with
HTLV-I
gag-pX gene, were found to release high levels of IL 2R constitutively. In contrast, this was not found in T cell lines in which
HTLV-I
was integrated but not expressed, human
immunodeficiency
virus (HIV)-infected T cell lines, or T cell, B cell, granulocyte and macrophage cell lines which were
HTLV-I
negative. These results raise the possibility that the pX-gene product might stimulate the generation of soluble IL 2R. In the sera from patients with adult T cell leukemia, large amounts of IL 2R were released, in contrast to sera from healthy carriers of
HTLV-I
. The molecular weight of IL 2R was determined to be about 50 KD by size-exclusion HPLC.
...
PMID:High levels of soluble interleukin 2 receptors released from human retrovirus-infected cells. 288 14
Sequential sera of 697 homosexual men, participating in a prospective study (1984-1986) of the risk to acquire human
immunodeficiency
virus (HIV) or AIDS, were tested for antibodies to human T-cell leukaemia virus (HTLV-I) by particle agglutination and immunoblotting. No intravenous drug users were included in this trial. Three men (0.4%) were HTLV-I antibody positive at intake and an additional 2 at the end of the observation period, resulting in an attack rate of approximately 0.3%. One of the 3 men with HTLV-I antibodies at intake was a Brazilian. One man had an acute
HTLV-I infection
after sexual intercourse with a Brazilian during holiday in Brazil. No serological cross-reactivity with HIV was observed nor a relationship with other sexually transmissible viral or bacterial infections. In contrast to HIV no relationship with anogenital intercourse was noted; both primary HTLV-I infected men practiced only orogenital intercourse. This suggests that HTLV-I was imported in the Dutch homosexual community after HIV was introduced in the Netherlands. HTLV-I appears to spread slower within the homosexual community than HIV and possibly by other routes.
...
PMID:Spread of human T-cell leukemia virus (HTLV-I) in the Dutch homosexual community. 289 Jul 4
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>